Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice

M Gredic, CY Wu, S Hadzic, O Pak… - European …, 2022 - Eur Respiratory Soc
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …

[PDF][PDF] Early View

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - 2021 - qdcxjkg.com
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary
disease (COPD), associated with increased mortality and morbidity. Intriguingly, pulmonary …

Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice

M Gredic, CY Wu, S Hadzic, O Pak… - European …, 2021 - Eur Respiratory Soc
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary
disease (COPD), associated with increased mortality and morbidity. Intriguingly, pulmonary …

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - The European …, 2022 - europepmc.org
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - EUROPEAN …, 2022 - pure.mpg.de
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice

M Gredic, CY Wu, S Hadzic, O Pak… - The European …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …

[PDF][PDF] Early View

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - 2021 - scholar.archive.org
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary
disease (COPD), associated with increased mortality and morbidity. Intriguingly, pulmonary …

[HTML][HTML] Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice

M Gredic, CY Wu, S Hadzic, O Pak… - The European …, 2022 - ncbi.nlm.nih.gov
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …

[PDF][PDF] Early View

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - 2021 - qdcxjkg.com
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary
disease (COPD), associated with increased mortality and morbidity. Intriguingly, pulmonary …

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.

M Gredic, CY Wu, S Hadzic, O Pak, R Savai… - The European …, 2022 - europepmc.org
Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …